In this study, immunohistochemistry results from human glioma samples corroborated the results from the TCGA data analysis showing elevated MTF2 expression in glioblastoma multiforme (GBM) and lower-grade glioma. This evidence concerns the gene MTF2 and central nervous system cancer.